Product features
Indirect chemiluminescent immunoassay (CLIA) to test IgM antibodies against Tick-borne encephalitis virus (TBEV) in human serum/plasma.
- Monotest format with ready-to-use reagents
- Simple and automated protocol with fast results
- Custom setup of samples and reagents
- Each monodose includes a calibrator and a negative control that enables the validation and interpretation of results for each individual sample
- Allows pipetting from primary sample tube, no further manipulation is needed
PRODUCTS
TICK BORNE ENCEPHALITIS VIRCLIA IgG MONOTEST
Analytes: Tick-borne encephalitis virus (TBEV)
TICK BORNE ENCEPHALITIS VIRCLIA IgM MONOTEST
Analytes: Tick-borne encephalitis virus (TBEV)
USED ON
VirClia Lotus
A compact automated CLIA platform for VirClia® infectious disease testing, combining ready-to-use single-test flexibility with continuous random access efficiency.
MORE RESOURCES
Related germs and organisms categorized for this product line.
Downloadable PDF materials, brochures, and technical documents.
The latest insights, news, and research articles from our scientific team.
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Beyond detection: H. pylori testing in today’s laboratory workflow
Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...
Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...
Scientific bibliography and references related to this product.
